NSN 6505-01-582-5875
Part Details | MENINGOCOCCAL GROUP
6505-01-582-5875
Alternate Parts: 9319099002866, 2950996, 15879, 6505NCM104263, NIMENRIX, NDC46028020801, NDC46028-0208-01, MENVEO, 6505-01-582-5875, 01-582-5875, 6505015825875, 015825875
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-582-5875
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 9319099002866 | ZBF76 | ANSPEC PTY LTD |
| 2950996 | B6095 | ASSOCIATION PHARMACEUTIQUE BELGE |
| 15879 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM104263 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NIMENRIX | B1672 | GLAXOSMITHKLINE PHARMACEUTICALS SA |
| NDC46028-0208-01 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
| MENVEO | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
Technical Data | NSN 6505-01-582-5875
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | 1 VIAL CONTAINING LYOPHILIZED MEN. A CONJUGATE COMPONENT AND 1 VIAL CONTAINING LIQUID MEN CYW-135 CONJUGATE COMPONENT ACTIVE INGREDIENT; EACH DOSE CONSISTS OF THE RECONSTITUTION OF THE LYOPHILIZED MEN. A COMPONENT WITH THE LIQUID MEN. CYW-135 CONJUGATE COMPONENT, 0.5 ML SOLUTION FOR IM INJECTION; PACKAGE OF 5 VIALS LIQUID COMPONENT AND 5 VIALS OF LYOPHILIZED COMPONENT, SUFFICIENT FOR 5 SINGLE DOSES; FOR IM USE; FOR IMMUNIZATION OF PERSONS 2-55 YEARS OF AGE; USED TO PREVENT INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135; DO NOT FREEZE; REQUIRES REFRIGERATION BETWEEN 2 AND 8 DEG C; REFRIGERATION IS ALSO REQUIRED DURING TRANSPORT; PROTECT FROM LIGHT |
| STORAGE TEMP RANGE | +2.0 TO +8.0 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MEN GROUPS A C Y AND W-135 OLIGOSACCHARIDE DIPH CRM CONJUGATE VACCINE FOR INJ MENVEO 5S |
